VALIRX PLC MARKETING AND COMMUNICATIONS UPDATE
London, UK., 10 July 2019: ValiRx Plc (AIM: VAL), the AIM-quoted clinical stage biotechnology company is pleased to announce a marketing and communications update for shareholders.
Dr Satu Vainikka, Chief Executive, will be delivering a presentation to investors at the SVS Securities and UK Investor Magazine investor evening on Thursday 18 July 2019 at the Skinners Hall, 8½ Dowgate Hill, London EC4R 2SP, which commences at 6:00pm (for registration) until 11:00pm.
Those wishing to register for this complimentary event may do so through the following link:
A copy of the presentation will be available to investors on the evening and will be available to view on the Company’s website shortly after the event.
- Tarquin Edwards